Doximity, Inc. (NASDAQ:DOCS – Get Free Report) CFO Anna Bryson sold 45,000 shares of the firm’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the transaction, the chief financial officer now owns 357,165 shares of the company’s stock, valued at $20,440,552.95. This trade represents a 11.19 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Doximity Stock Performance
Doximity stock opened at $59.26 on Friday. The stock has a market capitalization of $11.06 billion, a P/E ratio of 59.26, a P/E/G ratio of 4.10 and a beta of 1.41. The company’s fifty day moving average price is $59.10 and its 200 day moving average price is $56.60. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on DOCS. Raymond James reissued an “outperform” rating and issued a $83.00 price objective (up from $65.00) on shares of Doximity in a report on Friday, February 7th. Leerink Partnrs raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Bank of America upped their price objective on shares of Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Finally, Morgan Stanley lowered their price target on shares of Doximity from $71.00 to $60.00 and set an “equal weight” rating on the stock in a report on Thursday, April 24th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Doximity currently has an average rating of “Moderate Buy” and an average target price of $65.39.
Institutional Trading of Doximity
Several institutional investors have recently modified their holdings of the stock. Global Retirement Partners LLC lifted its position in shares of Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after acquiring an additional 440 shares in the last quarter. UMB Bank n.a. boosted its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after acquiring an additional 235 shares during the last quarter. Allworth Financial LP grew its stake in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company’s stock valued at $32,000 after buying an additional 287 shares during the period. Spire Wealth Management grew its position in Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after acquiring an additional 260 shares during the period. Finally, Larson Financial Group LLC grew its holdings in shares of Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after purchasing an additional 250 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Five stocks we like better than Doximity
- How to invest in marijuana stocks in 7 stepsĀ
- Meta Takes A Bow With Q1 Earnings – Watch For Tariff Impact in Q2
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious
- Are Penny Stocks a Good Fit for Your Portfolio?
- Palantir Earnings: 1 Bullish Signal and 1 Area of Concern
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.